MB-102 DMID
HDNP102-301
Phase 3 small_molecule completed
Quick answer
MB-102 DMID for Kidney Diseases is a Phase 3 program (small_molecule) at Hangzhou Zhongmei Huadong Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hangzhou Zhongmei Huadong Pharmaceutical Co.,
- Indication
- Kidney Diseases
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed